(Q72717479)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6196202%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Increased frequency of immunogenic variants obtained by repeated mutagen treatment of mouse mastocytoma P815 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6196202%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

26 August 2023

author name string

M. Marchand

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6196202

26 August 2023

P. Caspar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6196202

26 August 2023

T. Boon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6196202

26 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6196202

26 August 2023

publication date

1 November 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6196202%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

https://api.elsevier.com/content/article/PII:0277537983900822?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

https://api.elsevier.com/content/article/PII:0277537983900822?httpAccept=text/plain

26 August 2023

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

European Journal of Cancer & Clinical Oncology

26 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6196202%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6196202%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6196202%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

1529-1537

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6196202%20AND%20SRC:MED&resulttype=core&format=json

Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line

28 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic mice

26 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice

26 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis

26 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors

26 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line

26 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis

26 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response

26 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

26 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones

26 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VI. Occasional escape from host rejection due to antigen-loss secondary variants

26 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90082-2

26 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6196202%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference